IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Overview Fund Activity
Delisted

IDXG was delisted on the 24th of February, 2021.

Back to rankings

27 hedge funds and large institutions have $17.4M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$42.2K
2
Renaissance Technologies
Renaissance Technologies
New York
+$40.1K
3
ANTB
AMG National Trust Bank
Colorado
+$36K
4
HA
Heartland Advisors
Wisconsin
+$26.4K
5
MA
Minerva Advisors
Pennsylvania
+$21K

Top Sellers

1
RA
Royce & Associates
New York
-$432K
2
KCM
Kennedy Capital Management
Missouri
-$346K
3
Northern Trust
Northern Trust
Illinois
-$38.9K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$23.5K
5
BFA
BlackRock Fund Advisors
California
-$5.53K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$1K +$500 +2 +100%
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
Morgan Stanley
28
Morgan Stanley
New York
– -$5K -12 Closed
GSC
29
Ground Swell Capital
South Carolina
– -$2K -4 Closed
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
– -$31 – –
1
2